Beta-Blockers, Trimethoprim-Sulfamethoxazole, and the Risk of Hyperkalemia Requiring Hospitalization in the Elderly: A Nested Case-Control Study

Background and objectives: The simultaneous use of beta adrenergic receptor blockers (β-blockers) and trimethoprim-sulfamethoxazole (TMP-SMX) may confer a high risk of hyperkalemia. Design, setting, participants, & measurements: Two nested case-control studies were conducted to examine the assoc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Weir, Matthew A., Juurlink, David N., Gomes, Tara, Mamdani, Muhammad, Hackam, Daniel G., Jain, Arsh K., Garg, Amit X.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Nephrology 2010
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974392/
https://ncbi.nlm.nih.gov/pubmed/20595693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.01970310
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares